Volume 29, Issue 9 (12-2021)                   JSSU 2021, 29(9): 4057-4061 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Haji Zeinali A M. Trans-catheter Bioprosthetic Heart Valve Implantation in Iran (Tehran Heart Centre Experience). JSSU. 2021; 29 (9) :4057-4061
URL: http://jssu.ssu.ac.ir/article-1-5457-en.html
Abstract:   (465 Views)
Introduction: With the development of interventional cardiology in the world, in addition to coronary and aortic diseases, the treatment of heart valve diseases through catheters has recently begun. The treatment of aortic stenosis (which was only possible with open surgery and valve replacement) was first performed in the world in 2002 by Alain Cribier in France with catheter insertion of the valve and was called Trans catheter Aortic valve implantation TAVI. Trans catheter Aortic valve implantation (TAVI) was performed in Iran in 2009 in the Heart Centre of Tehran and now is routinely performed by both Balloon Expanding and self-expanding valves. In addition, we do valve in valve implantation for degenarative biopresthetic valve, in all Heart valve positions too. The short and medium term results of this treatment were reviewed in the form of research projects and published in several articles. In this review, we have explained the initiating of this new procedure in our country with the following results.
Full-Text [PDF 593 kb]   (197 Downloads)    
Type of Study: Letter to editor | Subject: Cardiovascular
Received: 2021/05/22 | Accepted: 2021/12/1 | Published: 2021/12/1

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | SSU_Journals

Designed & Developed by : Yektaweb